Discovering new cancer treatments in the “dark matter” of the human genome

Discovering new cancer treatments in the “dark matter” of the human genome
Cancer is in Switzerland the second leading cause of death. Among the different types of cancers, non-small cell lung cancer (NSCLC) kills the most patients and remains largely incurable. Unfortunately, even newly approved therapies can extend the life of patients only by a few months and only few survive the metastatic stadium long-term.